RDSNF (Redsense Medical AB) EPS (Basic): $-0.14 (TTM As of Mar. 2026)


RDSNF Redsense Medical AB RDSNF
54 GF Score
Price $0.51
GF Value $0.77
! 5 Warning Signs
View Full Analysis

What is Redsense Medical AB EPS (Basic)?

Redsense Medical AB RDSNF -51.43% 54 EPS (Basic) is $-0.14 as of Mar. 2026. GuruFocus rates RDSNF with a GF Score™ of 54/100 and a GF Value™ of $0.77. The stock has 5 warning signs investors should review.

Redsense Medical AB's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was $0.01. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.14.

Redsense Medical AB's EPS (Diluted) for the three months ended in Mar. 2026 was $0.01. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.14.

Redsense Medical AB's EPS without NRI for the three months ended in Mar. 2026 was $0.01. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was -0.14.

During the past 3 years, the average EPS without NRI Growth Rate was 3.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Redsense Medical AB's highest 3-Year average EPS without NRI Growth Rate was 14.60% per year. The lowest was -58.50% per year. And the median was -5.00% per year.

Redsense Medical AB  (OTCPK:RDSNF) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Redsense Medical AB EPS (Basic) Related Terms

Redsense Medical AB EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Redsense Medical AB's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Redsense Medical AB EPS (Basic) Chart

Redsense Medical AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.06 -0.06 -0.03 0.00 -0.05

Redsense Medical AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.02 -0.12 -0.02 -0.01 0.01
RDSNF
54GF Score
Redsense Medical AB RDSNF
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Redsense Medical AB EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Redsense Medical AB's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-0.772-0)/16.300
=-0.05

Redsense Medical AB's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(0.12-0)/15.986
=0.01

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of $-0.14 mean?
Redsense Medical AB (RDSNF) has a EPS (Basic) of $-0.14 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Redsense Medical AB and its competitors.
Is Redsense Medical AB's EPS (Basic) too high?
Redsense Medical AB's current EPS (Basic) is $-0.14. Overall, Redsense Medical AB has a GF Score™ of 54/100, reflecting its overall financial health beyond just this single metric.
How does Redsense Medical AB's EPS (Basic) compare to ABT and SYK?
Redsense Medical AB's EPS (Basic) of $-0.14 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Medical Devices & Instruments company?
A good EPS (Basic) depends on the Medical Devices & Instruments industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Redsense Medical AB and its competitors. Redsense Medical AB's current EPS (Basic) is $-0.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Redsense Medical AB stock overvalued right now?
Redsense Medical AB (RDSNF) has a current EPS (Basic) of $-0.14. The stock's GF Value™ is $0.77, compared to a current price of $0.51 — trading 33.8% below its estimated fair value. The current EPS (Basic) is $-0.14. Redsense Medical AB's overall GF Score™ is 54/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Redsense Medical AB (RDSNF), the current EPS (Basic) is $-0.14 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Redsense Medical AB (RDSNF) Overvalued in 2026?

Based on GuruFocus' analysis, Redsense Medical AB stock appears to be undervalued. The current stock price of $0.51 is trading 33.8% below its estimated GF Value™ of $0.77.

Key valuation signals for RDSNF:

  • EPS (Basic): $-0.14
  • GF Value™: $0.77 vs. price of $0.51 (33.8% below fair value)
  • GF Score™: 54/100 with 5 warning signs

No single metric tells the full story. See the RDSNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Redsense Medical AB Business Description

Other Exchanges REDS:Sweden
Address Storgatan 36, Halmstad, SWE, 302 43
Redsense Medical AB manufactures and sells blood loss detection devices in Sweden. The company has developed a monitoring system that can detect the first sign of a blood leak using patented fiber optic technology. The products of the company include Alarm Unit, Venous Needle Patch, Sensor Patch, and others.
54GF Score

Get the complete analysis for RDSNF

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.51
Price
$0.77
GF Value